1: Szabo S, Letsch R, Ehlers R, Walter T, Kazmaier S, Helber U, Hoffmeister HM. Related Articles, Links
Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase.
Thromb Res. 2002 Apr 15;106(2):113-9.
PMID: 12182909 [PubMed - in process]
2: Giugliano RP, McCabe CH, Antman EM, Cannon CP, Van de Werf F, Wilcox RG, Braunwald E. Related Articles, Links
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage.
Am Heart J. 2001 May;141(5):742-50.
PMID: 11320361 [PubMed - indexed for MEDLINE]
3: Wang-Clow F, Fox NL, Cannon CP, Gibson CM, Berioli S, Bluhmki E, Danays T, Braunwald E, Van De Werf F, Stump DC. Related Articles, Links
Determination of a weight-adjusted dose of TNK-tissue plasminogen activator.
Am Heart J. 2001 Jan;141(1):33-40.
PMID: 11136484 [PubMed - indexed for MEDLINE]
4: Van de Werf F, Cannon CP, Luyten A, Houbracken K, McCabe CH, Berioli S, Bluhmki E, Sarelin H, Wang-Clow F, Fox NL, Braunwald E. Related Articles, Links
Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators.
Am Heart J. 1999 May;137(5):786-91.
PMID: 10220625 [PubMed - indexed for MEDLINE]

Time used: 47 miliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005